FRA:MRK - Merck KGaA Stock Price, News, & Analysis

Get Started

€90.60 -0.24 (-0.26 %)

(As of 05/22/2019 04:00 PM ET)

Previous Close€90.84

Today's Range€89.04 - €91.00

52-Week Range€76.60 - €115.00

Volume506,608 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer, multiple sclerosis, infertility, growth deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as squamous cell carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments. The company also provides life science products and services for use in the discovery, development, and manufacture of drug therapies, as well as in laboratories; and specialty chemicals for use in displays, computer chips, surfaces, Integrated circuits, microelectronic systems, anti-reflection coatings, and cosmetics. It has alliances with Pfizer Inc., Bristol-Myers Squibb Company, Intrexon Corporation, Avillion LLP., F-star Delta Ltd, SFJ Pharmaceuticals Group, Alibaba Health, Checkmate Pharmaceuticals, Solvias, and Leap Therapeutics, Inc., as well as a collaboration with Daiichi Sankyo Company, Limited. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

Receive MRK News and Ratings via Email

Sign-up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange FRA

Industry Drug Manufacturers - Specialty & Generic

Sub-IndustryN/A

SectorMedical

Current SymbolFRA:MRK

Previous Symbol

CUSIPN/A

CIKN/A

Webhttp://www.merckgroup.com/

Phone+49-6151-720

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Employees51,039

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableOptionable

Merck KGaA (FRA:MRK) Frequently Asked Questions

What is Merck KGaA's stock symbol?

Merck KGaA trades on the FRA under the ticker symbol "MRK."

What price target have analysts set for MRK?

21 analysts have issued twelve-month price objectives for Merck KGaA's stock. Their predictions range from €82.00 to €115.00. On average, they expect Merck KGaA's stock price to reach €101.25 in the next year. This suggests a possible upside of 11.8% from the stock's current price. View Analyst Price Targets for Merck KGaA.

What is the consensus analysts' recommendation for Merck KGaA?

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merck KGaA in the last year. There are currently 1 sell rating, 14 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Merck KGaA.

Has Merck KGaA been receiving favorable news coverage?

Media stories about MRK stock have been trending negative recently, according to InfoTrie Sentiment. The research firm identifies positive and negative news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Merck KGaA earned a media sentiment score of -2.0 on InfoTrie's scale. They also gave news articles about the healthcare company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near future.

Who are some of Merck KGaA's key competitors?

Some companies that are related to Merck KGaA include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Biome Grow (BIO), Blueberries Medical (BBM), Cannabis Science (CBIS), Cannara Biotech (LOVE), Charlotte's Web (CWBHF), Choom (CHOOF), Cipher Pharmaceuticals (CPHRF), CLS Holdings USA (CLSH), Cosmos (COSM) and Curaleaf (CURLF).

What other stocks do shareholders of Merck KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merck KGaA investors own include Cisco Systems (CSCO), Micron Technology (MU), NVIDIA (NVDA), Boeing (BA), HDFC Bank (HDB), IBM (IBM), Netflix (NFLX), QUALCOMM (QCOM), Starbucks (SBUX) and Bank of America (BAC).

Who are Merck KGaA's key executives?

Merck KGaA's management team includes the folowing people:

Dr. Stefan Oschmann, Chairman of Exec. Board & CEO (Age 62)
Dr. Marcus Kuhnert, CFO & Member of Exec. Board (Age 51)
Dr. Kai Beckmann, CEO of Performance Materials & Member of the Exec. Board (Age 54)
Dr. Udit Batra, CEO of Life Science & Member of Exec. Board (Age 48)
Ms. Belén Garijo López M.D., CEO of Healthcare & Member of the Exec. Board (Age 59)

What is Merck KGaA's stock price today?

One share of MRK stock can currently be purchased for approximately €90.60.

What is Merck KGaA's official website?

The official website for Merck KGaA is http://www.merckgroup.com/.

How can I contact Merck KGaA?

Merck KGaA's mailing address is Frankfurter Strasse 250, DARMSTADT, 64293, Germany. The healthcare company can be reached via phone at +49-6151-720.

MarketBeat Community Rating for Merck KGaA (FRA MRK)

Community Ranking:		2.3 out of 5 ( )
Outperform Votes:		758 (Vote Outperform)
Underperform Votes:		857 (Vote Underperform)
Total Votes:		1,615

MarketBeat's community ratings are surveys of what our community members think about Merck KGaA and other stocks. Vote "Outperform" if you believe MRK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MRK will underperform the S&P 500 over the long term. You may vote once every thirty days.

This page was last updated on 5/22/2019 by MarketBeat.com Staff

Featured Article: How to interpret Moving Average Convergence Divergence (MACD)